Cleveland BioLabs
CBLI
#9795
Rank
HK$0.38 B
Marketcap
HK$24.66
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Cleveland BioLabs (CBLI)

Last known market cap: HK$0.38 Billion

As of December 2025 Cleveland BioLabs has a market cap of HK$0.38 Billion. This makes Cleveland BioLabs the world's 9795th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cleveland BioLabs from 2006 to 2022

End of year Market Cap

Year Marketcap Change
2022HK$0.38 B0.2%
2021HK$0.38 B9.91%
2020HK$0.34 B557.2%
2019HK$52.97 M-40.72%
2018HK$89.36 M-74.71%
2017HK$0.35 B192.09%
2016HK$0.12 B-59.29%
2015HK$0.29 B135.2%
2014HK$0.12 B-69.17%
2013HK$0.40 B-11.11%
2012HK$0.46 B-41.54%
2011HK$0.78 B-51.52%
2010HK$1.62 B213.81%
2009HK$0.51 B130.02%
2008HK$0.22 B-74.53%
2007HK$0.88 B90.92%
2006HK$0.46 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
HK$0.16 B-57.40%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
HK$8.08 B 2,019.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.368 T 358,469.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.015 T 527,930.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
HK$858.65 B 224,891.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$900.64 B 235,893.15%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
HK$765.44 B 200,468.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
HK$0.11 B-68.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.350 T 1,926,049.88%๐Ÿ‡บ๐Ÿ‡ธ USA